Covestro Past Earnings Performance
Past criteria checks 0/6
Covestro's earnings have been declining at an average annual rate of -19.4%, while the Chemicals industry saw earnings growing at 18.5% annually. Revenues have been growing at an average rate of 4.3% per year.
Key information
-19.4%
Earnings growth rate
-18.3%
EPS growth rate
| Chemicals Industry Growth | 13.1% |
| Revenue growth rate | 4.3% |
| Return on equity | -3.9% |
| Net Margin | -1.5% |
| Next Earnings Update | 31 Jul 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Covestro makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 17,968 | -272 | 1,929 | 361 |
| 30 Sep 22 | 18,342 | 929 | 1,977 | 359 |
| 30 Jun 22 | 18,026 | 1,389 | 1,974 | 371 |
| 31 Mar 22 | 17,279 | 1,639 | 1,931 | 362 |
| 31 Dec 21 | 15,903 | 1,616 | 1,861 | 341 |
| 30 Sep 21 | 14,572 | 1,626 | 1,759 | 330 |
| 30 Jun 21 | 13,030 | 1,333 | 1,653 | 298 |
| 31 Mar 21 | 11,230 | 832 | 1,527 | 270 |
| 31 Dec 20 | 10,706 | 459 | 1,529 | 262 |
| 30 Sep 20 | 10,563 | 184 | 1,593 | 253 |
| 30 Jun 20 | 10,965 | 152 | 1,649 | 254 |
| 31 Mar 20 | 12,020 | 393 | 1,756 | 263 |
| 31 Dec 19 | 12,412 | 552 | 1,783 | 266 |
| 30 Sep 19 | 12,820 | 594 | 1,809 | 275 |
| 30 Jun 19 | 13,360 | 943 | 1,852 | 276 |
| 31 Mar 19 | 14,012 | 1,358 | 1,905 | 276 |
| 31 Dec 18 | 14,616 | 1,823 | 1,924 | 276 |
| 30 Sep 18 | 14,866 | 2,310 | 1,922 | 275 |
| 30 Jun 18 | 14,696 | 2,305 | 1,897 | 278 |
| 31 Mar 18 | 14,331 | 2,185 | 1,859 | 278 |
| 31 Dec 17 | 14,138 | 2,009 | 1,859 | 274 |
| 30 Sep 17 | 13,633 | 1,567 | 1,874 | 267 |
| 30 Jun 17 | 13,123 | 1,335 | 1,860 | 266 |
| 31 Mar 17 | 12,615 | 1,081 | 1,846 | 260 |
| 31 Dec 16 | 11,904 | 795 | 1,815 | 259 |
| 30 Sep 16 | 11,685 | 587 | 1,755 | 261 |
| 30 Jun 16 | 11,683 | 488 | 1,708 | 257 |
Quality Earnings: 1COV N is currently unprofitable.
Growing Profit Margin: 1COV N is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1COV N is unprofitable, and losses have increased over the past 5 years at a rate of 19.4% per year.
Accelerating Growth: Unable to compare 1COV N's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 1COV N is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-37.2%).
Return on Equity
High ROE: 1COV N has a negative Return on Equity (-3.95%), as it is currently unprofitable.